Vaccinex : ASCO Conference Presentation - MarketScreener
Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate PEPINEMAB IN COMBINATION WITH PEMBROLIZUMAB for first-linetreatment...
Source: marketscreener.com
Nabilf Saba News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nabilf Saba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nabilf Saba Today - Breaking & Trending Today
Toripalimab Approval Pioneers Immunotherapy Use in Nasopharyngeal Cancer
Nabil F. Saba, MD, FACP, and Shravan Kandula, MD, highlight the significance of the approval of toripalimab for nasopharyngeal carcinoma; key data from JUPITER-02 and POLARIS-02 trials; and how the addition of this agent to the treatment armamentarium heightens the importance of multidisciplinary collaboration.
Source: onclive.com
Dr Saba on Findings from the CONTINUUM Trial of Sintilimab in Nasopharyngeal Cancer
Nabil F. Saba, MD, FACP, discusses key findings from the phase 3 CONTINUUM trial of sintilimab plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
Source: onclive.com
Winship and Cleveland Clinic receive NCI award to establish center to improve radiation-based combination therapies
The NCI recently awarded more than $7.9 million to support a new Radiation Oncology-Biology Integration Network (ROBIN) center at Winship Cancer Institute of Emory University and the Cleveland Clinic.
Source: emory.edu
Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at ASCO 2022 | Small Molecules
Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at ASCO 2022
Source: pipelinereview.com